Animal studies showed that combined transfer of tumour-specific CD8+ Tc and CD4+ Th cells significantly enhanced anti-tumour response, suggesting that both T cell subsets act synergistically and improve effectiveness of ACT in cancer patients [156,157]. This evidence concerns the gene CD8A and cancer.